vTv Therapeutics Analyst Price Targets - Benzinga

vTv Therapeutics Inc

VTVTNASDAQ

Trade with Public

Trade with Public

$30.08

-0.93-3%

마지막 업데이트: Oct 8, 7:48 AM

$33.00

1.996.42%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

vTv Therapeutics Analyst Price Targets - Benzinga

vTv Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for vTv Therapeutics (VTVT).

Price Target Range — 6 Quarters

Analyst Consensus — 6 Analysts

6Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$51Upside to Avg. PT+53.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 6, 2026	HC Wainwright & Co.	Emily Bodnar	PT Cut	Buy	$45→$42
Jul 16, 2026	BTIG	Kambiz Yazdi	PT Raise	Buy	$49→$57
Mar 12, 2026	Evercore ISI Group	Michael DiFiore	Initiate	Outperform	$44
Mar 11, 2026	BTIG	Kambiz Yazdi	Maintained	Buy	$49
Jan 27, 2026	BTIG	Kambiz Yazdi	PT Raise	Buy	$40→$49
Jan 23, 2026	Roth Capital	Adam Walsh	Initiate	Buy	$58
Jan 5, 2026	TD Cowen	Ritu Baral	Initiate	Buy	$67
Dec 19, 2025	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$36→$47
Nov 19, 2025	BTIG	Kambiz Yazdi	Initiate	Buy	$40
Aug 13, 2025	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$36
Apr 9, 2025	HC Wainwright & Co.	Emily Bodnar	Initiate	Buy	$36
Dec 9, 2024	Alliance Global Partners	James Molloy	Initiate	Buy	$35

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on vTv Therapeutics, Lowers Price Target to $42

HC Wainwright & Co. analyst Emily Bodnar maintains vTv Therapeutics (NASDAQ:VTVT) with a Buy and lowers the price target from $45 to $42.

Benzinga Newsdesk

Abbott To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Friday

Recent analyst rating changes, top names such as PPG, SAH, ISRG, MMM, OKE, GLDG, ABT, NFLX, TSCO, and SBAC were upgraded or downgraded.

Avi Kapoor

BlackRock To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on top names. See all changes, including upgrades and downgrades, on our analyst ratings page.

Avi Kapoor

PRO
BTIG Maintains Buy on vTv Therapeutics, Raises Price Target to $57

BTIG analyst Kambiz Yazdi maintains vTv Therapeutics (NASDAQ:VTVT) with a Buy and raises the price target from $49 to $57.

Benzinga Newsdesk

This Karman Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Wall Street analysts changed outlook on top names. See ratings page for upgrades, downgrades, and initiations. Analysts recommend H2O, KRMN, GNSS, WCN, and WM stocks.

Avi Kapoor

This Nio Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Avi Kapoor